François Vergez

4.0k total citations
68 papers, 1.3k citations indexed

About

François Vergez is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, François Vergez has authored 68 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Hematology, 24 papers in Molecular Biology and 20 papers in Genetics. Recurrent topics in François Vergez's work include Acute Myeloid Leukemia Research (40 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Chronic Myeloid Leukemia Treatments (9 papers). François Vergez is often cited by papers focused on Acute Myeloid Leukemia Research (40 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Chronic Myeloid Leukemia Treatments (9 papers). François Vergez collaborates with scholars based in France, United States and Italy. François Vergez's co-authors include Christian Récher, Éric Delabesse, Jean Emmanuel Sarry, Estelle Saland, Stéphane Manenti, Clément Larrue, Sarah Bertoli, Jérôme Tamburini, Suzanne Tavitian and Françoise Huguet and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

François Vergez

62 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
François Vergez France 18 601 559 309 301 181 68 1.3k
Zhongxing Jiang China 19 392 0.7× 607 1.1× 573 1.9× 503 1.7× 110 0.6× 79 1.5k
Nicholas Lea United Kingdom 19 832 1.4× 691 1.2× 270 0.9× 228 0.8× 516 2.9× 40 1.6k
Danielle M. Townsley United States 23 1.4k 2.3× 457 0.8× 550 1.8× 333 1.1× 383 2.1× 64 2.2k
J B Marriott United Kingdom 18 610 1.0× 641 1.1× 348 1.1× 346 1.1× 137 0.8× 26 1.3k
Aristeidis Chaidos United Kingdom 20 620 1.0× 578 1.0× 309 1.0× 363 1.2× 317 1.8× 70 1.4k
Utz Krug Germany 25 980 1.6× 1.1k 2.0× 233 0.8× 432 1.4× 282 1.6× 82 2.0k
Maximilian Stahl United States 25 1.3k 2.1× 970 1.7× 254 0.8× 466 1.5× 387 2.1× 121 2.0k
Yoshihiro Kameoka Japan 17 294 0.5× 563 1.0× 220 0.7× 330 1.1× 270 1.5× 64 1.3k
F. Dreyfus France 15 645 1.1× 462 0.8× 256 0.8× 441 1.5× 326 1.8× 56 1.2k
Heike Engel United States 15 683 1.1× 211 0.4× 512 1.7× 345 1.1× 190 1.0× 25 1.3k

Countries citing papers authored by François Vergez

Since Specialization
Citations

This map shows the geographic impact of François Vergez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Vergez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Vergez more than expected).

Fields of papers citing papers by François Vergez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Vergez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Vergez. The network helps show where François Vergez may publish in the future.

Co-authorship network of co-authors of François Vergez

This figure shows the co-authorship network connecting the top 25 collaborators of François Vergez. A scholar is included among the top collaborators of François Vergez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Vergez. François Vergez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alliot, Jean‐Marc, Pierre‐Yves Dumas, François Vergez, et al.. (2024). Artificial intelligence-based prediction models for acute myeloid leukemia using real-life data: A DATAML registry study. Leukemia Research. 136. 107437–107437. 10 indexed citations
2.
Vergez, François, et al.. (2023). Diagnosis of enteropathy‐associated T‐cell lymphoma (EATL) on peripheral blood: A pleiomorphic morphology and an unusual immunophenotype. SHILAP Revista de lepidopterología. 4(3). 861–862. 1 indexed citations
3.
Griessinger, Emmanuel, Diego A. Pereira‐Martins, Marielle Nebout, et al.. (2023). Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold. Cancer Research. 83(15). 2461–2470. 7 indexed citations
4.
Mouchel, Pierre‐Luc, Emilie Bérard, Suzanne Tavitian, et al.. (2023). Vitamin C and D supplementation in acute myeloid leukemia. Blood Advances. 7(22). 6886–6897. 10 indexed citations
5.
Vergez, François, et al.. (2023). Vacuolated lymphocytes as initial presentation of angioimmunoblastic T‐cell lymphoma. British Journal of Haematology. 203(2). 150–151.
6.
Bertoli, Sarah, Laëtitia Largeaud, Jean‐Baptiste Rieu, et al.. (2022). Prognostic Impact of Unsupervised Early Assessment of Bulk and Leukemic Stem Cell Measurable Residual Disease in Acute Myeloid Leukemia. Clinical Cancer Research. 29(1). 134–142. 11 indexed citations
7.
Comont, Thibault, Emmanuel Treiner, & François Vergez. (2021). From Immune Dysregulations to Therapeutic Perspectives in Myelodysplastic Syndromes: A Review. Diagnostics. 11(11). 1982–1982. 6 indexed citations
8.
Boulinguez, S., Jean‐Baptiste Rieu, Jean Vial, et al.. (2021). CD158k and PD-1 expressions define heterogeneous subtypes of Sezary syndrome. Blood Advances. 6(6). 1813–1825. 9 indexed citations
9.
Rieu, Jean‐Baptiste, Aurore Perrot, François Vergez, Laëtitia Largeaud, & Jill Corre. (2020). When dystrophic plasma cells do not recognize themselves in the mirror. SHILAP Revista de lepidopterología. 1(2). 408–408. 1 indexed citations
10.
Dumas, Pierre‐Yves, Sarah Bertoli, Emilie Bérard, et al.. (2020). Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study. Cancers. 12(8). 2044–2044. 5 indexed citations
11.
Rieu, Jean‐Baptiste, Jill Corre, Suzanne Tavitian, et al.. (2020). A case of cup‐like blasts associated with B‐lymphoblastic leukemia without NPM1 and FLT3 internal tandem duplication mutations. SHILAP Revista de lepidopterología. 1(2). 589–592. 1 indexed citations
12.
Tavitian, Suzanne, Sarah Bertoli, Françoise Huguet, et al.. (2020). Dactinomycin in acute myeloid leukemia with NPM1 mutations. European Journal Of Haematology. 105(3). 302–307. 9 indexed citations
13.
Bertoli, Sarah, Jean‐Baptiste Rieu, Christian Récher, & François Vergez. (2020). Large granular lymphocytosis during quizartinib therapy. British Journal of Haematology. 189(1). 7–7. 1 indexed citations
14.
Vergez, François, Marie-Laure Nicolau-Travers, Sarah Bertoli, et al.. (2020). CD34+CD38−CD123+ Leukemic Stem Cell Frequency Predicts Outcome in Older Acute Myeloid Leukemia Patients Treated by Intensive Chemotherapy but Not Hypomethylating Agents. Cancers. 12(5). 1174–1174. 11 indexed citations
15.
Bertoli, Sarah, Étienne Paubelle, Emilie Bérard, et al.. (2018). Ferritin heavy/light chain (FTH1/FTL) expression, serum ferritin levels, and their functional as well as prognostic roles in acute myeloid leukemia. European Journal Of Haematology. 102(2). 131–142. 69 indexed citations
16.
Larrue, Clément, Estelle Saland, François Vergez, et al.. (2015). Antileukemic Activity of 2-Deoxy- d -Glucose through Inhibition of N-Linked Glycosylation in Acute Myeloid Leukemia with FLT3-ITD or c-KIT Mutations. Molecular Cancer Therapeutics. 14(10). 2364–2373. 61 indexed citations
17.
Bossis, Guillaume, Jean-Emmanuel Sarry, Estelle Saland, et al.. (2014). The ROS/SUMO Axis Contributes to the Response of Acute Myeloid Leukemia Cells to Chemotherapeutic Drugs. Cell Reports. 7(6). 1815–1823. 79 indexed citations
18.
Vergez, François, Alexa S. Green, Jérôme Tamburini, et al.. (2011). High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study. Haematologica. 96(12). 1792–1798. 147 indexed citations
19.
LaRochelle, Olivier, Sarah Bertoli, François Vergez, et al.. (2011). Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience. Oncotarget. 2(11). 850–861. 22 indexed citations
20.
Vergez, François, Jean‐Emmanuel Sarry, Nathalie Gallay, et al.. (2010). Anti-Leukemic Activity of PIK-75, a PI3-Kinase p110α Selective Inhibitor, In Acute Myeloid Leukemia. Blood. 116(21). 659–659.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhongxing Jiang Breakdown of academic impact, for papers by Nicholas Lea Breakdown of academic impact, for papers by Danielle M. Townsley Breakdown of academic impact, for papers by J B Marriott Breakdown of academic impact, for papers by Aristeidis Chaidos Breakdown of academic impact, for papers by Utz Krug Breakdown of academic impact, for papers by Maximilian Stahl Breakdown of academic impact, for papers by Yoshihiro Kameoka Breakdown of academic impact, for papers by F. Dreyfus Breakdown of academic impact, for papers by Heike Engel
Rankless by CCL
2026